Medical Hematology | Medical XPRT
Articles & Whitepapers
-
Innovative Diagnostic Development Urges Rare Disease Therapies
Rare diseases are characterized by their low prevalence, affecting a small number of people across the world. These diseases often come with significant challenges, including accurate diagnosis, availability of effective treatments, and limited resources for research and development. However, recent advancements in diagnostics technology hold promise for speeding up the field of rare disease ...
-
Why Sterile Packaging is Crucial for Medical Devices
Patients who need medical treatment often fear being exposed to harmful germs and unsanitary instruments. Just the thought of a healthcare provider using an unsterilized surgical device or needle ...
News
-
Neurescue`s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
New device offers a mouthful of data for chronic diseases
Wired: This startup wants to stop deaths from cardiac arrest?
Infection Control Resources to Identify Klebsiella and Other Pathogens in Healthcare Settings throughout Puerto Rico
Infection Control Resources to Mitigate Patient Exposure Risks to Klebsiella and Other Pathogens
Equipment & Solutions
-
Showcase
POCT Immunofluorescence Quantitative Analyzer
The POCT Immunofluorescence Quantitative Analyzer is used cooperatively with special fluoroimmunoassay reagent strips and applicable to fluoroimmunoassay of human body samples. The product can be used for semiquantitative and quantitative immunoassay of medical, antiepidemic and scientific research institutions.